News & Press | September 30, 2025
The INsight Quarterly Newsletter: September 2025
What multi-omics trends are building momentum and driving new opportunities in biomarker-guided drug development?
Keep abreast of the latest news and innovations across proteomics, metabolomics, biocomputational analysis and AI-aided drug development, and more with The INsight newsletter, offering resources to sponsors and researchers that share how these advances are moving drug development forward.
In this issue:
- A pioneering study reveals dynamic human chemistry shaped by biology & environment
- Moving beyond DNA and RNA for target identification and biomarker discovery
- The impact of integrating multi-omics and real-world data in predictive modeling
- Why drug development is due for disruption to enable the next therapeutic breakthroughs
Want these insights delivered directly to your inbox? Subscribe today to automatically receive upcoming editions of Sapient’s quarterly newsletter.